GEHC: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025
⚠ AI Risk Brief Interpretation layer — deterministic data below

GEHC removed 18 regulatory risk factors, suggesting reduced compliance burden or improved regulatory clarity in 2025.

Direction ↓ Less concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

0
New Risks
18
Removed
13
Modified
21
Unchanged
🔴 No Match in Current Filing Disclosure change8/10

Our business operations are subject to extensive laws and regulations, and any changes thereto or violations thereof could have a material adverse effect on our business.

This section from the 2024 filing does not have a high-confidence textual match in the 2025 filing. It may have been removed, merged, or substantially reworded.

🔴 No Match in Current Filing The U.S. FDA and other regulatory agencies actively enforce the laws and regulations governing the development, approval, and clearance and commercialization of medical devices and pharmaceutical products. 🔒
🔴 No Match in Current Filing Compliance with laws and regulations applicable to the manufacture and distribution of our products outside the United States may be costly, and failure to comply may result in significant penalties. 🔒
🔴 No Match in Current Filing The misuse or off-label use of our products may harm our reputation or, if we are deemed to have engaged in the promotion of these uses, result in costly investigations, fines, or sanctions by regulatory bodies. 🔒

And 27 more changes in the full comparison.

30 changes in this historical filing

The complete historical comparison (2025 vs 2024) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →